• Profile
Close

Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified?

The Breast Journal Oct 16, 2017

Sorrentino L, et al. - Researchers sought to determine preoperative features predictive of nodal involvement in patients with ductal carcinoma in situ (DCIS) of the breast. Exclusion from sentinel node biopsy may not always be sufficiently justified by a preoperative diagnosis of DCIS, including advanced biopsy systems such as vacuum-assisted breast biopsy. In addition, axillary evaluation was recommended to be considered in DCIS patients with associated Breast Imaging Reporting and Data System (BI-RADS) >4, lesion extension ≥20 mm, comedo type, and above all multifocal disease.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay